Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human Hematopoietic Stem Cell Vulnerability to Ferroptosis

ABSTRACT: Human Hematopoietic Stem Cell Vulnerability to Ferroptosis

PROVIDER: PRJNA913143 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22768346_1.fastq.gz	Fastqsanger.gz
	SRR22768346_2.fastq.gz	Fastqsanger.gz
	SRR22768347_1.fastq.gz	Fastqsanger.gz
	SRR22768347_2.fastq.gz	Fastqsanger.gz
	SRR22767485.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Human Hematopoietic Stem Cell Vulnerability to Ferroptosis [Ribosome profiling]

Project description:Human Hematopoietic Stem Cell Vulnerability to Ferroptosis [Ribosome profiling]

| PRJNA913269 | ENA

Human Hematopoietic Stem Cell Vulnerability to Ferroptosis [scRNA-seq]

Project description:Human Hematopoietic Stem Cell Vulnerability to Ferroptosis [scRNA-seq]

| PRJNA915208 | ENA

Human hematopoietic stem cell vulnerability to ferroptosis.

Project description:Hematopoietic stem cells (HSCs) have a number of unique physiologic adaptations that enable lifelong maintenance of blood cell production, including a highly regulated rate of protein synthesis. Yet, the precise vulnerabilities that arise from such adaptations have not been fully characterized. Here, inspired by a bone marrow failure disorder due to the loss of the histone deubiquitinase MYSM1, characterized by selectively disadvantaged HSCs, we show how reduced protein synthesis in HSCs results in increased ferroptosis. HSC maintenance can be fully rescued by blocking ferroptosis, despite no alteration in protein synthesis rates. Importantly, this selective vulnerability to ferroptosis not only underlies HSC loss in MYSM1 deficiency but also characterizes a broader liability of human HSCs. Increasing protein synthesis rates via MYSM1 overexpression makes HSCs less susceptible to ferroptosis, more broadly illustrating the selective vulnerabilities that arise in somatic stem cell populations as a result of physiologic adaptations.

| S-EPMC9978939 | biostudies-literature

Hematopoietic stem cells (HSCs)

Project description:G0 marker-separation of dormant and active hematopoietic stem cells reveals dormancy regulation by basal cytoplasmic calcium

2019-12-19 | PXD012093 | JPOST Repository

Human Hematopoietic Stem Cell Vulnerability to Ferroptosis

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-02-17 | GSE221170 | GEO

ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression [ChIP-Seq]

Project description:Ferroptosis, a non-apoptotic programmed cell death triggered by excessive iron-dependent lipid peroxidation, plays a pivotal role in tumor progression. Significant progress has been made in elucidating the role of transcription factors in the regulation of ferroptosis. Nevertheless, the identification of the key transcription factor responsible for inducing ferroptosis remains elusive. In this study, we discovered that ATOH8 is upregulated in prostate cancer cells treated with the ferroptosis inducer. Overexpression of ATOH8 increased the vulnerability of prostate cancer to ferroptosis, while ATOH8 deletion promotes ferroptosis evasion. Mechanistically, ATOH8 suppresses the transcription of SCD, reducing the synthesis of monounsaturated fatty acids that confer resistance to ferroptosis. Additionally, ATOH8 works in conjunction with the E protein E47 to form a transcriptional repression complex that inhibits SCD transcription. Furthermore, we discovered that EZH2 epigenetically suppresses the expression of ATOH8 through DNA methylation and H3K27 methylation. Interestingly, EZH2 was found to be downregulated in ferroptosis, resulting in an upregulation of ATOH8. Pharmacological inhibition of EZH2 combined with ferroptosis inducer significantly suppresses prostate cancer growth in vitro and in vivo. Together, our findings unveil that EZH2-mediated ATOH8 downregulation promotes ferroptosis evasion and suggest that pharmacological manipulation of EZH2 and ATOH8 is a promising therapeutic strategy for prostate cancer.

2025-01-30 | GSE282996 | GEO

ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression [RNA-Seq]

2025-01-30 | GSE282995 | GEO

Transcriptomes of cultured human hematopoietic stem cells.

Project description:Transcriptomes of cultured human hematopoietic stem cells.

| PRJNA791215 | ENA

Newly defined human hematopoietic stem cell populations

Project description:Newly defined human hematopoietic stem cell populations

| PRJNA808797 | ENA

Human hematopoietic stem cell engraftment in goat

Project description:Human hematopoietic stem cell engraftment in goat

| PRJNA90277 | ENA